戻る Agenda
[V1-S3] Raise the Curtain of “Patient Centricity” in Japan (Part II): Learn by Trial and Error
Session Chair(s)
Norie Miki-Yasuda, PhD
Head of Clinical Operations Europe, Canada, Australia & New Zealand
Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
Kaori Muto, PhD
Professor, Department of Public Policy, The Institute of Medical Science
The University of Tokyo, Japan
The idea of Patient Centricity and Patient and Public Engagement are increasingly attracting interest in Japan, while their concept and idea have not been organized among various stakeholders. In this session , pharmaceutical companies will share their activities for patient centricity in clinical trials and discuss Patient Centricity and Patient and Public Engagement together with the speakers of the part 1 session.
Speaker(s)
Innovating with the Patient, for the Patient
Andreas Koester, MD, PhD
Janssen Research & Development, LLC, United States
Vice President and Global Head, Clinical Innovation
Pharma Company's Patient Centric Activities
Atsushi Kitamura, MS
Pfizer R&D Japan G.K., Japan
Director, Clinical Development Quality
Utilization of Patient Voice to Study Planning
Kazuyuki Suzuki, MSc
Novartis Pharma K.K., Japan
Senior Lead strategy & Execution Patient Engagement group Cuntry Comms & Patient
Jin Higashijima, PhD
Yamaguchi University, Japan
Associate Professor, Faculty of Global and Science Studies
Ikuko Yamaguchi
NPO COML, Japan
Board Chairperson